新冠明星疫苗企业缩减10亿美元研发,在华投资不确定性增加

第一财经
13 Sep 2024

在新冠期间市值暴增的美国明星疫苗企业Moderna(莫德纳)正在走下“神坛”。该公司在当地时间9月12日于纽约举行的年度研发日投资者会议上,宣布削减超过10亿美元研发开支,致使公司当天股价暴跌超过12%,股价创下四年来新低。截至美股9月12日收盘,Moderna市值仅约268亿美元,较新冠期间的千亿美元市值峰值缩水约四分之三。Moderna首席执行官斯蒂芬·班塞尔(Stephane Bancel)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10